Stock A182400 NKMAX CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart NKMAX CO., Ltd.

Equities

A182400

KR7182400002

End-of-day quote Korea S.E.
Other stock markets
 07:00:00 2024-03-24 pm EDT 		5-day change 1st Jan Change
2,020 KRW +9.54% Intraday chart for NKMAX CO., Ltd. -.--% -67.58%
May. 16 NKMAX CO., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 17 NKMAX CO., Ltd. cancelled the transaction announced on October 20, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NKMAX CO., LTD. Stock NKMAX CO., Ltd.
 126M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
BIONTECH SE Stock BioNTech SE
 23.83B -
ARGENX SE Stock argenx SE
 21.73B -
GENMAB A/S Stock Genmab A/S
 18.1B
  1. Stock Market
  2. Equities
  3. A182400 Stock
  4. Charts NKMAX CO., Ltd.
  5. Sector Chart